Papers on cell-free DNA (#cfDNA). Maintained by @TeifLab. Also see @nucleosome_bot, @CTCF_papers, @DNAbinding, @TF_binding_bot @generegulation

Joined July 2019
cfDNA papers 📚 NucPosDB database retweeted
Nucleosome aficionados! Our new review "Nucleosome spacing across cell types, diseases, and ages" is out in NAR: academic.oup.com/nar/article… A huge effort to pull together what we’ve learned about nucleosome spacing in many systems. Enjoy! #nucleosomics #nucleosome #chromatin #cfDNA
24
1
103
6,228
cfDNA papers 📚 NucPosDB database retweeted
Great to see that this preprint used our software NucTools to calculate NRL, and reached conclusions confirming our previous paper, which reported effect of linker histones H1 on cfDNA fragmentation patterns and nucleosome spacing in cancer tissues/cfDNA link.springer.com/article/10…
5
1
12
1,553
cfDNA papers 📚 NucPosDB database retweeted
We have a postdoctoral opening for a researcher with experience in bioinformatics of DNA sequencing and machine learning to work on the development of new methods for cancer diagnostics related to nucleosomes, chromatin and more jobs.ac.uk/job/DMK060/senior…. Apply by 21st April 2025!
12
2
20
5,193
cfDNA papers 📚 NucPosDB database retweeted
💡Will #ctDNA serve as a treatment response biomarker in metastatic cancers? Here’s a thorough evaluation in @CCR_AACR from the RECIST working group, looking at the next steps towards using ctDNA for novel early endpoints in clinical trials and beyond. 👉 doi.org/10.1158/1078-0432.CC…
2
31
1
83
9,290
cfDNA papers 📚 NucPosDB database retweeted
Very happy to contribute to this paper about cfDNA in SCLC, led by the team of Anish Thomas. It's already online in Genome Medicine: Takahashi et al., Genomic alterations and transcriptional phenotypes in circulating free DNA and matched metastatic tumor genomemedicine.biomedcentral…
1
2
17
1,331
cfDNA papers 📚 NucPosDB database retweeted
Interesting preprint on nucleosome spacing from cfDNA [Johnston et al., 2024] biorxiv.org/content/10.1101/…. The authors refer to NRL changes 10n -> 10n-5 bp. Earlier we showed that NRL decrease in cancer is more complex & context-specific [Jacob et al., 2024] link.springer.com/article/10…
7
37
4,670
cfDNA papers 📚 NucPosDB database retweeted
We have an opening for a three-year postdoctoral position for a researcher with expertise in machine learning and genome bioinformatics, to work on cancer diagnostics (liquid biopsies). Please apply here: vacancies.essex.ac.uk/tlive_…
1
23
2
24
4,850
cfDNA papers 📚 NucPosDB database retweeted
Based on the ECLIPSE trial, @US_FDA today approved the Guardant SHIELD blood test for #ColorectalCancer. @matthewherper in @statnews statnews.com/2024/07/29/guar… See ECLIPSE data below & why individuals undergoing this assay should clearly understand - this is NOT a test for CRC PREVENTION (it has very low sensitivity for adenomas, including adenomas with high grade dysplasia, where sensitivity is in the low teens). SHIELD is at best a test for DETECTION of CRC, and even in this setting, half to a third of Stage 1 cancers might be missed. The full details are on this document that detail the FDA approval label accompanying SHIELD: shieldcancerscreen.com/wp-co…
Two studies in @nejm on non-invasive detection of #ColorectalCancer 1: Blood based cfDNA assay (@GuardantHealth) nejm.org/doi/full/10.1056/NE… 2: Stool based multi target DNA test (@ExactSciences). A🧵 on comparative numbers 👉🏽 Sensitivity for ALL CANCER Dx: cfDNA: ~83%; Stool: ~94% Sensitivity for STAGE 1 cancer Dx: cfDNA: ~65%; Stool: ~85% Sensitivity for advanced adenomas (polyps >10mm in size, villous adenomas, high grade dysplasia): cfDNA: ~13% (no significant difference listed for HGD); Stool: ~43% (~75% for HGD) Specificity for actionable lesions: cfDNA: ~90%; Stool: ~91% False positive rates: cfDNA: ~10%; Stool: ~ 8% Positive predictive value for cancer in average risk population: cfDNA: 3.2%; Stool: 3.4% Overall, the single most important difference lies in greater sensitivity of the stool based assay over cfDNA based assay for detection of early stage cancers & advanced adenomas (in particular, presence of HGD). As a GI #pathologist, we would note the presence of HGD in polyps and not want to miss these changes. The differences between the two assays is in some respects not a surprise since the blood test requires shed DNA to enter the circulation (which is less proportionate with non-invasive or early lesions), versus being shed in the stool. In general, biospecimens obtained at sites most proximal to the source of the lesion tend to be more sensitive (this is also seen with pancreatic cyst fluid versus blood for cystic neoplasms). Overall, ANY non invasive test is better than no testing for #ColorectalCancer but these nuances in sensitivity for early stage and advanced precancers should be kept in mind. COI: I am listed as an inventor on a patent that is licensed by Johns Hopkins to Thrive Earlier Detection (now an Exact Sciences company). Different assay and different cancer (pancreatic cancer) but important to disclose.
19
1
47
15,897
cfDNA papers 📚 NucPosDB database retweeted
Interesting news from @GrailBio trial in the UK - accuracy in the article given as 56% One of the main issues I think with Galleri is its model trained on late stage disease, and is a “fixed” panel. We need broader WG assays trained on early disease hsj.co.uk/quality-and-perfor…
5
5
1
17
5,875
cfDNA papers 📚 NucPosDB database retweeted
Our paper on nucleosome repositioning in breast cancer is now published in Clinical Epigenetics! clinicalepigeneticsjournal.b… ▶️Nucleosome gain marks deregulated TFs ▶️Shorter distances between nucleosomes in cancer ▶️NRL affected by gene expression, methylation, H1 histones, repeats
4
21
3
69
10,711
cfDNA papers 📚 NucPosDB database retweeted
Read the latest from @enseqlopedia on my blog: enseqlopedia.com/2024/02/pus… Priming agents to increase cfDNA levels for #liquidbiopsy by @broadinstitute @MIT @OmicsOmicsBlog @AlbertVilella @SanDiegOmics @mehtamanal this is some pretty #coolscience I know you'll be interested in.
1
3
1
15
8,508
cfDNA papers 📚 NucPosDB database retweeted
Excited to present the first ageing clock based on nucleosomics of cell-free DNA (cfDNA)! onlinelibrary.wiley.com/doi/… ✅ Nucleosome repeat length increases with age ✅ Can predict age with ~3 year precision Congrats to @MShtumpf, @nrnflowers, @Milena_Bikova, @hulkar_m, @LumiRuje!
5
64
5
243
29,658
Keeping a track on leptomeningeal disease in non-small cell lung cancer: A single-institution experience with CNSideTM dlvr.it/T1BfxX
144
Plasma cell-free DNA as a sensitive biomarker for multi-cancer detection and immunotherapy outcomes prediction dlvr.it/T1BfxR
3
175
Circulating free DNA and its potential in the diagnostics and therapy of malignant lymphoma dlvr.it/T1BfxL
2
135
The role of microRNAs involved in the disorder of blood-brain barrier in the pathogenesis of multiple sclerosis dlvr.it/T1Bfx7
1
109
Comprehensive Genomic Analysis of Patients With Non-Small-Cell Lung Cancer Using Blood-Based Circulating Tumor DNA Assay: Findings From the BFAST Database of a Single Center in Taiwan dlvr.it/T1BfvJ
2
115
Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer dlvr.it/T197Lf
111
Liquid Biopsy: An Evolving Paradigm for Non-invasive Disease Diagnosis and Monitoring in Medicine dlvr.it/T18JxF
87